Cyclin D RxL inhibitor (Circle Pharma)

N/A

Report date: 2025/04/21 16:57:10

NME

Base Information

Drug NameCyclin D RxL inhibitor (Circle Pharma)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin D inhibitors

TargetsCyclin D

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCircle Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A